Orthocell's Remplir™ Technology: A Game Changer in Prostate Cancer Surgery Orthocell Limited's Remplir™ is gaining traction in prostate cancer surgeries, enhancing patient recovery and showing promise for future expansion in the market.

Orthocell's Remplir™ Technology: A Game Changer in Prostate Cancer Surgery #Australia #Prostate_Cancer #Perth #Orthocell #Remplir_Technology

Remplir™ Revolutionizes Prostate Cancer Surgery with Nerve-Sparing Technique Orthocell's Remplir™ is a groundbreaking device in nerve-sparing prostate cancer surgery, aiming to minimize complications such as erectile dysfunction and urinary incontinence post-operation.

Remplir™ Revolutionizes Prostate Cancer Surgery with Nerve-Sparing Technique #Australia #Prostate_Surgery #Perth #Orthocell #Remplir™

Remplir™ Study Shows Promising 81% Success Rate in Nerve Repair Treatment The latest Remplir™ study reveals an impressive 81.1% success rate in nerve repair, supporting sales efforts in the US and EU regulatory submissions.

Remplir™ Study Shows Promising 81% Success Rate in Nerve Repair Treatment #Australia #Perth #Remplir #Orthocell #Nerve_Repair